+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Epilepsy"

Neurology. A Clinical Handbook. Edition No. 1 - Product Thumbnail Image

Neurology. A Clinical Handbook. Edition No. 1

  • Book
  • August 2022
  • 496 Pages
Epilepsy. Edition No. 2 - Product Thumbnail Image

Epilepsy. Edition No. 2

  • Book
  • April 2021
  • 544 Pages
Geriatric Neurology. Edition No. 1 - Product Thumbnail Image

Geriatric Neurology. Edition No. 1

  • Book
  • April 2014
  • 744 Pages
Epilepsy in Women. Edition No. 1 - Product Thumbnail Image

Epilepsy in Women. Edition No. 1

  • Book
  • February 2013
  • 232 Pages
European Handbook of Neurological Management. Edition No. 2 - Product Thumbnail Image

European Handbook of Neurological Management. Edition No. 2

  • Book
  • October 2011
  • 360 Pages
  • Europe
The Treatment of Epilepsy. 3rd Edition - Product Thumbnail Image

The Treatment of Epilepsy. 3rd Edition

  • Book
  • July 2009
  • 1116 Pages
Neurology. A Queen Square Textbook. Edition No. 3 - Product Thumbnail Image

Neurology. A Queen Square Textbook. Edition No. 3

  • Book
  • April 2024
  • 1280 Pages
Loading Indicator

Epilepsy is a neurological disorder characterized by recurrent seizures. It affects people of all ages and is one of the most common neurological disorders worldwide. Treatment options for epilepsy include medications, lifestyle changes, and surgery. The goal of treatment is to reduce the frequency and severity of seizures. The epilepsy market is a subset of the larger neurology market. It is composed of pharmaceutical companies, medical device companies, and other healthcare providers. Pharmaceutical companies develop and market antiepileptic drugs (AEDs) to treat epilepsy. Medical device companies develop and market devices such as vagus nerve stimulators and responsive neurostimulators to treat epilepsy. Other healthcare providers, such as neurologists, provide diagnosis and treatment of epilepsy. Some companies in the epilepsy market include Pfizer, GlaxoSmithKline, Johnson & Johnson, Medtronic, Abbott, and UCB. Show Less Read more